Skip to main content

Table 1 Patient and treatment characteristics (n = 74)

From: Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)

Gender

Female/male

15/59

Age

Median

55

 

Range

28–75

PS

0/1

56/18

WHO type

I/II/III

7/33/34

Clinical stage

II/III/IVA/IVB

16/33/13/12

T stage

1/2/3/4

22/15/22/15

N stage

0/1/2/3

5/26/31/12

Courses of concurrent CT

2/3

17/57

Courses of adjuvant CT

0/1/2/3

15/5/15/39

  1. CT Chemotherapy